A preclinical study of EpCAM-targeted therapy for human hepatocellular carcinoma with stem cell features

被引：0
|
作者：
Tanaka, Shinji [1 ]
Ogawa, Kousuke [1 ]
Matsumura, Satoshi [1 ]
Aihara, Arihiro [1 ]
Ban, Daisuke [1 ]
Ochiai, Takanori [1 ]
Irie, Takumi [1 ]
Kudo, Atsushi [1 ]
Arii, Shigeki [1 ]
Tanabe, Minoru [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1369
引用
收藏
页码：857A / 857A
页数：1
相关论文
共 50 条
  • [31] Discrete nature of EpCAM+ and CD90+cancer stem cells in human hepatocellular carcinoma
    Yamashita, Taro
    Honda, Masao
    Nakamoto, Yasunari
    Baba, Masayo
    Nio, Kouki
    Hara, Yasumasa
    Zeng, Sha Sha
    Hayashi, Takehiro
    Kondo, Mitsumasa
    Takatori, Hajime
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Ikeda, Hiroko
    Zen, Yoh
    Takamura, Hiroyuki
    Wang, Xin Wei
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 57 (04) : 1484 - 1497
  • [32] Radioiodine Gene Therapy of Hepatocellular Carcinoma Targeted Human Alpha Fetoprotein
    Jin, Yong Nan
    Chung, Hye Kyung
    Kang, Joo Hyun
    Lee, Yong Jin
    Kimm, Kwang Il
    Kim, Young Joo
    Kim, Seunghoo
    Chung, June-Key
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (05) : 551 - 560
  • [33] Stem cell, biomaterials and growth factors therapy for hepatocellular carcinoma
    Jaferian, Soleiman
    Soleymaninejad, Maryam
    Negahdari, Babak
    Eatemadi, Ali
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 : 1046 - 1053
  • [34] Genomic Profiling of Cell Lines for Personalized Targeted Therapy for Hepatocellular Carcinoma
    Deshmukh, Manjeet
    Hoshida, Yujin
    HEPATOLOGY, 2013, 58 (06) : 2207 - 2207
  • [35] CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
    Palaz, Fahreddin
    Ozsoz, Mehmet
    Zarrinpar, Ali
    Sahin, Ilyas
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 975 - 995
  • [36] Visualization of stem cell features in human hepatocellular carcinoma; tumor-host interaction and clinical imapct
    Tanaka, Shinji
    Muramatsu, Shunsuke
    Aihara, Arihiro
    Adikrisna, Rama
    Mogushi, Kaoru
    Matsumura, Satoshi
    Ban, Daisuke
    Ochiai, Takanori
    Irie, Takumi
    Kudo, Atsushi
    Nakamura, Noriaki
    Nakayama, Koh
    Tanaka, Hiroshi
    Yamaoka, Shoji
    Tanabe, Minoru
    Arii, Shigeki
    HEPATOLOGY, 2013, 58 : 1083A - 1083A
  • [37] EpCAM-positive cancer stem cells acquired chemoresistance in hepatocellular carcinoma
    Pandit, Harshul
    Li, Yan
    Cui, Guozhen
    Li, Xuanyi
    Li, Suping
    Yang, Yingbin
    Rostas, Jack
    Martin, Robert C. G.
    CANCER RESEARCH, 2016, 76
  • [38] Development of Human Hepatocellular Carcinoma Cell-Targeted Protein Cages
    Toita, Riki
    Murata, Masaharu
    Tabata, Shigekazu
    Abe, Kana
    Narahara, Sayoko
    Piao, Jing Shu
    Kang, Jeong-Hun
    Hashizume, Makoto
    BIOCONJUGATE CHEMISTRY, 2012, 23 (07) : 1494 - 1501
  • [39] Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signaling
    Endaya, Berwini
    Guan, Shou P.
    Newman, Jennifer P.
    Huynh, Hung
    Sia, Kian C.
    Chong, Siao T.
    Kok, Catherine Y. L.
    Chung, Alexander Y. F.
    Liu, Bin B.
    Hui, Kam M.
    Lam, Paula Y. P.
    ONCOTARGET, 2017, 8 (33) : 54629 - 54639
  • [40] Glucose targeted therapy against liver hepatocellular carcinoma: In vivo study
    Mazumder, Anisha
    Assawapanumat, Wirat
    Dwivedi, Anupma
    Reabroi, Somrudee
    Chairoungdua, Arthit
    Nasongkla, Norased
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 49 : 502 - 512
12345